Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2023 16:01 ET | Source: Celcuity Inc.

Celcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial in Metastatic Castration Resistant Prostate Cancer

- Received FDA clearance of IND for gedatolisib in combination with darolutamide - Virtual Science Day to be held on September 21, 2023 from 10:00 a.m. – 12:00 p.m. ET MINNEAPOLIS, Aug. 22, 2023 ...
August 10, 2023 16:04 ET | Source: Celcuity Inc.

Celcuity Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

Phase 3 VIKTORIA-1 clinical trial is now recruiting patients at nearly 200 sites in 20 countriesPresented updated results from Phase 1b study of gedatolisib in treatment-naïve advanced breast cancer...
August 03, 2023 07:30 ET | Source: Celcuity Inc.

Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that it...
July 31, 2023 08:00 ET | Source: Celcuity Inc.

Celcuity to Participate in the BTIG Virtual Biotechnology Conference 2023

MINNEAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that...